Tower Research Capital (TRC)’s PROLOR Biotech, Inc. Common Stock PBTH Stock Holding History

Tower Research Capital (TRC)’s Portfolio PBTH Stock Details PBTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-820	Closed	-$5K	–	5249
2013 Q2	$5K	Buy	+820	New	+$4.91K	﹤0.01%	3026

Other funds holding PBTH

Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

CDH

Charles D. Hyman $1.79B AUM 17.18% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $128B AUM 35.83% 1-Year Est. Return

Tower Research Capital (TRC)'s PBTH Position: Q3 2013 in Review

Tower Research Capital (TRC) sold out of PROLOR Biotech, Inc. Common Stock (PBTH) in Q3 2013, closing a stake of 820 shares — an estimated $5K sold.

Tower Research Capital (TRC) first reported a position in PBTH in Q2 2013 and held it in 1 quarter. The position peaked at $5K in Q2 2013. 3 funds tracked by Wall St. Rank hold PBTH as of Q3 2013.

Tower Research Capital (TRC) reported no remaining PROLOR Biotech, Inc. Common Stock position as of Q3 2013 after selling out during the quarter.
Tower Research Capital (TRC) sold 820 PROLOR Biotech, Inc. Common Stock shares in Q3 2013, an estimated $5K.
Tower Research Capital (TRC) first reported a position in PROLOR Biotech, Inc. Common Stock in Q2 2013 and held it in 1 quarter.
Tower Research Capital (TRC)'s PROLOR Biotech, Inc. Common Stock position peaked at $5K in Q2 2013.
3 funds tracked by Wall St. Rank held PROLOR Biotech, Inc. Common Stock as of Q3 2013.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2013, filed 6 Nov 2013.